Those adjustments just keep coming. As SFGATE reported, Genentech announced 436 layoffs in April 2024, and 93 more layoffs ...

Bharat Biotech joins GSK to develop a Shigella vaccine to fight shigellosis in children, with Phase 3 trials underway and ...

Bharat Biotech has partnered with GSK to advance the Shigella vaccine altSonflex1-2-3. With strong early trial results and no ...

Behind the veneer of accessibility lies a critical bottleneck in clinical trial readiness, especially pronounced in trials ...

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid ...

Bharat Biotech to advance development of GSK's Shigella vaccine candidate for severe bacterial diarrhoea: Our Bureau, Bengaluru Thursday, June 12, 2025, 15:30 Hrs [IST] Bharat Bio ...

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to ...

The spinout, dubbed Antares Therapeutics, will be fueled by a $177 million series A round co-led by Omega Funds, Atlas ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy ...

Oncolytics Biotech (TSX:ONC), a clinical-stage oncology immunotherapy stock, is up by more than 20 per cent after onboarding ...

Hyderabad: Bharat Biotech International Limited has announced that it has partnered with GSK plc for the ongoing development and potential use of the Shigella vaccine candidate, ...